NeuroMetrix Company Profile (NASDAQ:NURO)

Analyst Ratings

Consensus Ratings for NeuroMetrix (NASDAQ:NURO) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.25 (267.65% upside)

Analysts' Ratings History for NeuroMetrix (NASDAQ:NURO)
Show:
DateFirmActionRatingPrice TargetActions
7/22/2016Rodman & RenshawReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/29/2016Dawson JamesReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/11/2015Maxim GroupInitiated CoverageBuy$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2014 forward)

Earnings

Earnings History for NeuroMetrix (NASDAQ:NURO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
10/20/2016        
7/21/2016Q216($0.93)($5.37)$1.22 million$2.65 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/21/2016Q116($0.95)($1.00)$2.65 million$2.28 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2015Q315($0.08)($0.26)$6.47 million$2.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/22/2015Q215($0.48)$9.80 million$1.22 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/21/2015Q115($0.25)$1.33 million$1.28 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/12/2015Q414($0.36)$4.62 million$1.41 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2014Q314($0.19)$1.31 million$1.43 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2014Q413($0.85)$1.16 million$1.34 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/13/2014($0.87)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2013Q313($0.26)$1.77 million$1.31 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2013Q2 2013($0.92)$2.20 million$1.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2011($0.17)($0.18)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for NeuroMetrix (NASDAQ:NURO)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for NeuroMetrix (NASDAQ:NURO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for NeuroMetrix (NASDAQ:NURO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/1/2016Shai GozaniCEOBuy2,500$1.71$4,275.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2016Francis X McgillinVPBuy1,000$1.65$1,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2016Shai GozaniCEOBuy12,000$1.55$18,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2016Thomas T HigginsCFOBuy3,200$1.54$4,928.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2015Thomas T HigginsCFOBuy4,500$0.92$4,140.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2015Thomas T HigginsCFOBuy5,500$0.91$5,005.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/11/2015Shai GozaniCEOBuy16,300$0.91$14,833.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/9/2012Shai GozaniCEOBuy26,800$0.55$14,740.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2012Krishnamurthy BalachandranCOOBuy5,000$0.67$3,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/21/2012Thomas T HigginsCFOBuy5,000$0.64$3,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2012Krishnamurthy BalachandranCOOBuy5,000$0.70$3,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2012Thomas T HigginsCFOBuy5,000$0.70$3,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for NeuroMetrix (NASDAQ:NURO)
DateHeadline
07/22/16 05:24 PMChecking in on Stock Volatility for: NeuroMetrix Inc. (NASDAQ:NURO) - Engelwood Daily
07/22/16 05:24 PMRevenue Update on Neurometrix Inc(NASDAQ:NURO) - TheFounders Daily
07/22/16 11:31 AMNeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q2, 2016 By the Numbers : July 22, 2016 -
07/21/16 06:22 PMEdited Transcript of NURO earnings conference call or presentation 21-Jul-16 12:00pm GMT -
07/21/16 05:51 PMNeuroMetrix Reports Q2 2016 Financial Results and Highlights
07/21/16 08:27 AMInsiders Increasing Positions in: NeuroMetrix Inc. (NASDAQ:NURO) - Press Telegraph
07/14/16 09:07 AMNeuroMetrix Quell Device Makes Second Appearance at the American Podiatric Medical Association Annual Scientific Meeting
07/14/16 06:18 AMNeuroMetrix, Inc. Announces Date for 2016 Second Quarter Financial Results Conference Call - [at noodls] - WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it plans to issue its 2016 second quarter financial results before the opening of the market on Thursday July 21, ...
07/13/16 06:13 AMNeuroMetrix Expands DPNCheck Commercialization in Mexico - [at noodls] - WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (NURO) today reported commercial expansion of DPNCheck in Mexico following receipt of a purchase order from one of Mexico's six major government healthcare ...
07/12/16 10:13 AMNeuroMetrix' Quell Device Makes Second Appearance at the American Podiatric Medical Association Annual Scientific Meeting - [at noodls] - 100% Drug Free, FDA Cleared Wearable for Widespread Relief from Chronic Pain WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell Wearable Pain Relief Technology ...
07/12/16 10:00 AMNeuroMetrix’ Quell Device Makes Second Appearance at the American Podiatric Medical Association Annual Scientific Meeting - [Business Wire] - NeuroMetrix, Inc. today announced that Quell® Wearable Pain Relief Technology™ will be featured for the second year in a row at the American Podiatric Medical Association’s Annual Scientific Meeting to be held July 14-17 in Philadelphia.
07/07/16 06:21 AMNeuroMetrix Announces Launch of Quell Sport Electrode - [at noodls] - WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) today announced commercial launch of a new Sport Electrode for its innovative Quell Wearable Pain Relief Technology™. The new electrode ...
07/06/16 06:21 AMNeuroMetrix Reports Peer-Reviewed Publication of Initial Quell Study - [at noodls] - WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), today reported publication of the initial Quell study in the Journal of Pain Research. The paper is titled 'Fixed-Site High-Frequency ...
07/04/16 10:13 AMNeuroMetrix (NYSE:NURO) target price increased to $5 as covered today by Rodman & Renshaw
06/30/16 08:26 AMNeuroMetrix (NURO), WBC Group Enter Quell Distribution Agreement
06/28/16 12:28 PMNeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016 -
06/28/16 10:31 AMNeuroMetrix Announces Quell Distribution Agreement with WBC Group - [at noodls] - WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that WBC Group, LLC will be the exclusive distributor of Quell Wearable Pain Relief Technology to chiropractors, physical ...
06/28/16 06:05 AMCoverage initiated on NeuroMetrix by Rodman & Renshaw -
06/22/16 10:15 AMNeuroMetrix (NURO) Announces Submission of CE Application for Quell
06/22/16 06:29 AMNeuroMetrix Submits CE Mark Application for Quell Wearable Pain Relief Device - [at noodls] - WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that a CE (Conformité Européenne) Technical File Application for Quell has been submitted to TŰV SŰD Product Service GmbH, ...
06/21/16 06:19 AMNeuroMetrix Showcases Quell Technology at the Western Foot & Ankle Conference - [at noodls] - 100% Drug Free, FDA Cleared Wearable for Widespread Relief from Chronic Pain WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell Wearable Pain Relief Technology™ ...
06/14/16 05:18 PMNeuroMetrix (NURO) Says Quell Tech Now Available via Amazon.ca
06/14/16 01:49 PMNeuroMetrix Announces Quell Distribution in Canada - [at noodls] - WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Quell Wearable Pain Relief Technology is available in Canada via Amazon Canada. ... This is an abstract of the original ...
06/10/16 10:49 AMNeuroMetrix Reports Executive Stock Transactions during May 2016 - [at noodls] - WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) which developed and markets Quell Wearable Pain Relief Technology, reported purchases during May 2016 of the company's common stock by ...
06/09/16 06:09 AMNeuroMetrix Showcases Quell Technology at SLEEP 2016, the 30th Anniversary Meeting of the Associated Professional Sleep Societies - [at noodls] - WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell Wearable Pain Relief Technology will be featured at SLEEP 2016, which is a joint meeting of the American Academy ...
06/08/16 03:48 PMNeuroMetrix Closes $21.3 Million At-The-Market Private Placement of Preferred Stock and Warrants and Redeems $13.8 Million of Outstanding Preferred Stock - [at noodls] - WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) reported that it has closed its previously announced private placement of preferred stock and warrants. The Company sold to a healthcare ...
06/06/16 06:18 AMNeuroMetrix Celebrates 20 Year Anniversary - [at noodls] - WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it is celebrating its twenty year anniversary. ... This is an abstract of the original noodl. To continue reading ...
06/03/16 03:12 PMNEUROMETRIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securit -
06/02/16 03:45 PMNeuroMetrix Announces $21.3 Million at the Market Private Placement of Preferred Stock and Warrants - [at noodls] - WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ: NURO) announced today that it entered into a definitive securities purchase agreement with a healthcare dedicated institutional investor in ...
06/02/16 03:20 PM4:20 pm NeuroMetrix enters into securities purchase agreement with an institutional investor in connection with a 21,300 share private placement of series C convertible preferred stock at $1,000/share for gross proceeds of $21.3 mln -
06/02/16 06:25 AMNeuroMetrix Announces Availability of Quell in Approximately 1,000 Chain Drug Stores - [at noodls] - WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Quell will be available, beginning in June 2016, in approximately 1,000 chain drug stores as part of a retail test ...
05/31/16 10:00 AMNeuroMetrix to Present at the LD Micro Invitational Conference on June 7, 2016 - [Business Wire] - NeuroMetrix, Inc. today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the upcoming LD Micro Invitational at the Luxe Sunset Bel Air Hotel in Los Angeles, CA.
05/29/16 11:24 AMAnalysts Set 1-Year Price Target Of $3 On NeuroMetrix, Inc. (NASDAQ:NURO) Stock - RealistInvestor.com - Analysts Set 1-Year Price Target Of $3 On NeuroMetrix, Inc. (NASDAQ:NURO) StockRealistInvestor.comSell-side analysts reveal their outlook on NeuroMetrix, Inc. (NASDAQ:NURO) stock. As of 2016-05-27, the stock has ABR of 1. This methodology prompts shareholders to invest in stock if it has a rating of 1. The ABR was known considering the price ...and more »
05/27/16 11:41 AMNeuroMetrix Reports the Launch of the Quell® Health Cloud for Android - Business Wire (press release) - NeuroMetrix Reports the Launch of the Quell® Health Cloud for AndroidBusiness Wire (press release)WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), announced today the launch of the Quell Health Cloud for Android The updated Android app allows consumers to set up accounts on the Quell Health Cloud where their data is ...and more »
05/27/16 11:41 AMNeuroMetrix, Inc. (NASDAQ:NURO) Impact Score At 0 - Investor Newswire - NeuroMetrix, Inc. (NASDAQ:NURO) Impact Score At 0Investor NewswireAlpha One explored various online articles released on NeuroMetrix, Inc. (NASDAQ:NURO), and it set a daily sentiment score of 0 on the company. The entity has an algorithm in place to know stock sentiment on the share after exploring the content issued ...and more »
05/27/16 11:41 AMNeuroMetrix launches the Quell Health Cloud for Android - WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), announced today the launch of the Quell Health Cloud for Android The updated Android app allows consumers to set up accounts on the Quell Health Cloud where their data is automatically ...
05/26/16 06:07 AMNeuroMetrix Reports the Launch of the Quell® Health Cloud for Android - [at noodls] - WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), announced today the launch of the Quell Health Cloud for Android The updated Android app allows consumers to set up accounts on the Quell ...
05/24/16 11:53 AMFrancis Mcgillin, an Insider in Neurometrix Inc (NASDAQ:NURO), Paid for 1000 shares of the Company - Wall Street Hints and News - Francis Mcgillin, an Insider in Neurometrix Inc (NASDAQ:NURO), Paid for 1000 shares of the CompanyWall Street Hints and NewsThe Senior VP – Consumer of Neurometrix Inc and company's insider Francis Mcgillin bought 1,000 shares of the firm based on the avg. market share price which was $1.7 for share . The reported shares approximately $1,650 US Dollars. Francis is trying to ...Neurometrix, Inc. (NURO) Files Form 4 Insider Buying : Francis X Mcgillin Buys 1000 SharesMarket DigestThe Senior VP, Consumer of Neurometrix (NASDAQ: NURO) is Buying SharesAnalyst RatingsNeuroMetrix Officer Acquires –—,……… SharesGuruFocus.comall 4 news articles »
05/23/16 05:54 PMNeuroMetrix Officer Acquires –—,……… Shares -
05/20/16 11:38 AMWhat after Thomas Higgins's Insider Acquisition of Neurometrix Inc (NASDAQ:NURO) Stock? - Wall Street Hints and News - What after Thomas Higgins's Insider Acquisition of Neurometrix Inc (NASDAQ:NURO) Stock?Wall Street Hints and NewsAn insider of the company Neurometrix Inc, Thomas Higgins also its Senior Vice President – CFO, disclosed his well-informed investment activities with the U.S. SEC on May 19, 2016. As disclosed in the document, Thomas had purchased 3,200 shares of the ...and more »
05/18/16 12:02 PMAlpha One Assigns Impact Score Of 0 To NeuroMetrix, Inc. (NASDAQ:NURO) - Investor Newswire - Alpha One Assigns Impact Score Of 0 To NeuroMetrix, Inc. (NASDAQ:NURO)Investor NewswireAlpha One analyzed the various web articles published on NeuroMetrix, Inc. (NASDAQ:NURO), and thereafter it gave company a daily sentiment score of 0.132. The entity designs algorithm based assessment to known stock sentiment on stock after ...and more »
05/18/16 06:42 AMNeuroMetrix Announces Frank McGillin, SVP and General Manager, Consumer to participate in a Digital Health Summer Summit Panel at BIO 2016 - [at noodls] - WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced that Frank McGillin, Senior Vice President and General Manager, Consumer will participate in a panel discussion entitled 'The ...
05/16/16 06:32 AMNeuroMetrix Announces Availability of Quell at Brookstone.com - [at noodls] - WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that Quell is now available at Brookstone.com. ... This is an abstract of the original noodl. To continue reading this ...
05/12/16 12:17 PMNeuroMetrix Announces Launch of National TV Campaign to Support Quell - [at noodls] - WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) has launched national television advertising to promote the company's innovative Quell Wearable Pain Relief Technology™. The high impact ...
05/12/16 05:56 AMNeuroMetrix, Inc. (NASDAQ:NURO) Latest Impact Score At 100 - Investor Newswire - NeuroMetrix, Inc. (NASDAQ:NURO) Latest Impact Score At 100Investor NewswireNeuroMetrix, Inc. (NASDAQ:NURO) has a 0 daily sentiment score given by Alpha One after scanning articles on various online news platform. Alpha One performs algorithm based analysis to reach stock sentiment based on content published on different ...and more »
05/05/16 03:04 PMNEUROMETRIX, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of S -
04/28/16 05:38 AMNeuroMetrix, Inc. (NASDAQ:NURO) Has An Impact Score Of 100 - Investor Newswire - NeuroMetrix, Inc. (NASDAQ:NURO) Has An Impact Score Of 100Investor NewswireNeuroMetrix, Inc. (NASDAQ:NURO) has been given a 0.01 daily sentiment score for the related articles published on web today. Alpha One offer algorithm-based analytics, which can help state stock sentiment based on the content published on different ...and more »
04/25/16 09:45 AMNeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q1, 2016 By the Numbers -
04/24/16 05:36 AMQ1 Results: Neurometrix Inc (NURO) - share market updates (press release) - share market updates (press release)Q1 Results: Neurometrix Inc (NURO)share market updates (press release)Shares of Neurometrix Inc (NASDAQ:NURO) ended Friday session in red amid volatile trading. The shares closed down -0.05 points or -2.75% at $1.77 with 22,969.00 shares getting traded. Post opening the session at $1.80, the shares hit an intraday low of ...
04/22/16 10:30 AMNeuroMetrix to Present at First Look Equities Summit - [at noodls] - WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) announced today that Shai N. Gozani, M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the First Look Equities ...

Social

About NeuroMetrix

NeuroMetrix logoNeuroMetrix, Inc. (NeuroMetrix) is a health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians manage chronic pain, nerve diseases and sleep disorders. The Company operates through the sale of medical equipment and consumables segment. Its products are sold in the United States and selected overseas markets. It has two principal product lines: Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The Company's products consist of a medical device used in conjunction with a consumable electrode or biosensor. Its products include Quell, which is a wearable device for relief of chronic intractable pain; SENSUS, which is a prescription neuro-stimulation device; DPNCheck, which is a nerve conduction test that is used to evaluate systemic neuropathies, and ADVANCE System, which is a platform for the performance of nerve conduction studies.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NURO
  • CUSIP:
Key Metrics:
  • Previous Close: $1.72
  • 50 Day Moving Average: $1.77
  • 200 Day Moving Average: $1.70
  • P/E Ratio: N/A
  • P/E Growth: -0.04
  • Market Cap: $7.46M
  • Beta: 0.53
  • Current Year EPS Consensus Estimate: $-3.09 EPS
  • Next Year EPS Consensus Estimate: $-0.81 EPS
Additional Links:
NeuroMetrix (NASDAQ:NURO) Chart for Saturday, July, 23, 2016